Ponoi Management, LLC
CIK 1720702 · last filed 2023-01-25
Ponoi Management, LLC is a corporate insider who has filed 12 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider bought $494.9K of NGM on Jan 25, 2023. Across all open-market trades the lifetime net is +$85.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $53.1M across reported positions. The firm reports its address in San Francisco, CA. 97 SEC filings were submitted jointly with PONOI CAPITAL, LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NGM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BUILDING D, SUITE M-900
SAN FRANCISCO, CA 94129
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | 10%+ Owner | 12,072,323 | $1.54 | $18.59M | $84.96M | 10 | 2023-01-25 |
| NRIX | 10%+ Owner | 2,080,607 | $25.51 | $53.08M | $0 | 1 | 2021-05-07 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | 10%+ Owner | 4,757,094 | $33.99 | $161.69M | $0 | 1 | 2018-07-23 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-25 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +99,000 | $494.9K | EDGAR |
| 2023-01-23 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +381,390 | $1.91M | EDGAR |
| 2022-05-31 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +229,110 | $3.09M | EDGAR |
| 2021-05-07 | NRIX | Other (J) | −26,782,010 | $0 | EDGAR |
| 2020-04-09 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +1,126,020 | $16.83M | EDGAR |
| 2020-04-02 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +2,509,840 | $31.11M | EDGAR |
| 2020-02-10 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +449,000 | $7.17M | EDGAR |
| 2019-08-05 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +43,820 | $612.4K | EDGAR |
| 2019-07-26 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +898,660 | $12.12M | EDGAR |
| 2019-07-23 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +677,420 | $9.14M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.